GleamWall
中文EN

BICX BioCorRx Inc.

Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1443863 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-78.9%
TTM net income YoY51.3%
TTM EPS YoY52.0%
Revenue 3-yr CAGR-10.2%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-3,921.4%
Net margin-1,837.6%
FCF margin—
EBITDA margin-4,007.3%

Returns

ROE—
ROA-43.8%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets826.2%
Debt / equity—
Current ratio0.06x
Interest coverage-30.03x

Cash quality & payout

Operating cash flow / net income0.93x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302024Q12025-03-312024Q4*2024-12-31
Income statement
Revenue-$40,348$87,970$214,539-$151,118$213,910$178,238$134,899$0
Cost of revenue$2,625$144,967$25,184—$0$0$0$0
Gross profit-$42,973-$56,997$189,355—$213,910$178,238$134,899$0
R&D expense$746,064$712,384$352,333$305,516$1.00M$296,860$161,919$272,543
SG&A expense$601,248$686,323$775,453$539,366$902,594$1.22M$886,083$839,193
Operating income-$1.40M-$1.47M-$956,000-$534,185-$1.77M-$1.41M-$937,946-$1.12M
Interest expense$37,377$37,377$31,041$39,186$60,495$36,686$87,483$128,054
Pretax income-$810,673-$1.00M-$859,892-$471,218-$811,332-$1.38M-$851,764-$1.23M
Income tax$0$0$0$0$0$0$0$0
Net income-$797,134-$964,774-$831,227$552,555-$847,091-$1.23M-$841,407-$1.27M
EBITDA-$1.39M-$1.46M-$944,805-$658,989-$1.69M-$1.34M-$913,103-$1.11M
EPS (diluted)-0.03-0.03-0.03—-0.05-0.07-0.06—
Weighted avg. shares (diluted)30.10M29.22M25.60M—18.56M17.01M15.09M—
Banking
Noninterest income——————$10,357$63,018
Balance sheet
Cash & equivalents$18,233$21,237$211,911$139,360$287,688$111,872$24,142$88,033
Receivables$0$67,694$330,348$253,459$194,442$51,242$111,966$0
Inventory$164,118$43,551$143,425$143,425$155,367$133,597$133,597$0
Current assets$528,740$623,377$1.02M$814,468$1.46M$527,483$565,796$117,996
PP&E, net$0$0$1,452$4,062$7,685$11,083$15,213$18,977
Goodwill$563,158$563,158$563,158$563,158$2.84M$2.84M$2.84M$0
Intangibles$532,645$541,119$549,501$564,460$3.01M$3.08M$3.15M$7,848
Total assets$1.79M$1.91M$2.32M$2.15M$7.53M$6.68M$6.80M$385,941
Current liabilities$9.18M$8.85M$8.53M$8.31M$15.04M$14.56M$13.44M$8.21M
Short-term debt$103,521——$0————
Total liabilities$14.82M$14.38M$13.95M$13.67M$20.30M$19.69M$18.60M$12.74M
Shareholders' equity-$12.76M-$12.22M-$11.45M-$11.22M-$13.48M-$12.62M-$11.56M-$12.12M
Shares outstanding30.52M29.67M28.91M24.49M11.21M17.28M16.90M13.30M
Cash flow statement
Operating cash flow-$179,615-$440,289-$432,971-$847,722-$634,447-$126,499-$689,623-$247,170
Financing cash flow$176,611$249,615$505,522$699,394$810,263$214,229$625,732$335,113
Depreciation & amortization$8,474$9,834$11,195-$124,804$71,987$71,977$24,843$13,004
Stock-based compensation$0$0$108,375$149,760$30,715$0$151,257$285,533

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.